KBC Group’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
GS
GA
KBC Group's CDNA Position: Q2 2026 in Review
KBC Group held its CareDx (CDNA) position steady in Q2 2026 at 2,018 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #1659.
KBC Group first reported a position in CDNA in Q3 2024 and has held it in 8 quarters since. The position peaked at $99K in Q3 2024. 70 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- KBC Group held 2,018 shares of CareDx worth $58K as of Q2 2026.
- KBC Group left its CareDx share count unchanged in Q2 2026.
- CareDx made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1659 holding.
- KBC Group first reported a position in CareDx in Q3 2024 and has held it in 8 quarters since.
- KBC Group's CareDx position peaked at $99K in Q3 2024.
- 70 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.